未登录

X

Xiuyun Tian

Peking University

H指数:21

被引数:1,859

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence ( vol 44 , pg 565 , 2020)

ONCOLOGY REPORTS

IF3.9

2025-11-010

PRE

Oncogenic and Immunological Roles of FRS2 and its Potential Value in Retroperitoneal Liposarcoma: from Bioinformatics Analysis to Clinicopathological Evidence

FRS2在腹膜后脂肪肉瘤中的致癌和免疫学作用及其潜在价值：从生物信息学分析到临床病理学证据

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

IF3.2

2025-03-100

OA

Integrated lipidomics and RNA-seq reveal prognostic biomarkers in well-differentiated and dedifferentiated retroperitoneal liposarcoma

CANCER CELL INTERNATIONAL

IF6

2024-12-180

OAAI

Combination of eribulin and anlotinib exerts synergistic cytotoxicity in retroperitoneal liposarcoma by inducing endoplasmic reticulum stress

CELL DEATH DISCOVERY

IF7

2024-08-080

OAAI

Optimizing surgical strategies for retroperitoneal liposarcoma: a comprehensive evaluation of standardized aggressive surgical policies

IF3.4

2024-07-180

OAAI

Rapid and Precise Diagnosis of Retroperitoneal Liposarcoma with Deep-Learned Label-Free Molecular Microscopy

ANALYTICAL CHEMISTRY

IF6.7

2024-05-290

PRE

Long non-coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR-522 (vol 25, 71, 2022)

MOLECULAR MEDICINE REPORTS

IF3.5

2024-02-280

OAAI

Efficacy and safety of eribulin plus anlotinib and camrelizumab in advanced or metastatic retroperitoneal liposarcoma (RLPS) or leiomyosarcoma (RLMS): A singlecenter retrospective cohort study

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

Identification of the ?-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer

ANNALS OF MEDICINE

IF4.3

2023-08-062

OAAI

Delayed gastric emptying after aggressive surgery for retroperitoneal sarcoma - Incidence, characteristics, and risk factors

BIOSCIENCE TRENDS

IF5

2023-02-281

OA

Multidimensional characteristics, prognostic role, and preoperative prediction of peritoneal sarcomatosis in retroperitoneal sarcoma

FRONTIERS IN ONCOLOGY

IF3.3

2022-10-272

OAAI

Longitudinal and time-to-event modeling for prognostic implications of radical surgery in retroperitoneal sarcoma

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2022-07-043

OA

Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

IF3.2

2022-01-014

OAAI

Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence

Siglec-15在RLPS中的表达和功能及其与PD-L1的相关性: 生物信息学分析和临床病理证据

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

IF3.2

2022-01-014

OAAI

Macroscopically complete excision is a beneficial strategy for selected patients with peritoneal sarcomatosis

BIOSCIENCE TRENDS

IF5

2021-12-311

OA

Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma

FRONTIERS IN ONCOLOGY

IF3.3

2021-11-187

OAAI

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma

预测胰腺导管腺癌患者预后的免疫相关特征的鉴定

FRONTIERS IN ONCOLOGY

IF3.3

2021-02-2418

OAAI

Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinoma

IF5.1

2020-11-018

PREAI

Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2020-08-0121

PREAI

Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence

ONCOLOGY REPORTS

IF3.9

2020-06-0510

OAAI